spacer
  Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
spacer
spacer CDC Centers for Disease Control and Prevention Home Page spacer
CDC en EspaƱol
spacer
Search:  
spacer
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
spacer
spacer
spacer
Public Health Training Network
spacer
  PHTN
space
arrow Home
space
arrow What is PHTN?
space
arrow PHTN Calendar
space
arrow Our Catalog
space
arrow News Flash
space
arrow Public Health Image Library
space
spacer spacer
spacer
Skip Nav spacer
Course Overview

HPV and Cervical Cancer: An Update on Prevention Strategies
A National Center for HIV, STD & TB and
Public Health Training Network Webcast
Centers for Disease Control and Prevention

Originally aired August 9, 2005
1:00 PM 2:00 PM ET

Webcast Only

View Webcast


Genital Human Papilloma Virus (HPV) infection is one of the most common sexually transmitted infections. There is considerable new information about the natural history of HPV infection, the association of different HPV types with various clinical manifestations, HPV transmission, and methods of HPV prevention. In addition, the Food and Drug Administration recently approved the use of a commercially available HPV DNA test for two purposes: 1) for the management of patients with abnormal Pap test results; and 2) as an adjunct to the Pap test for cervical cancer screening in women 30 years and older. Currently, there is recognition that this new information may require different approaches to cervical cancer screening in primary care practices, and when counseling and educating patients and their sex partners. This webcast will provide viewers with information on cervical cancer screening guidelines and strategies for preventing genital HPV infection, including appropriate patient counseling messages.
Goal
To increase provider knowledge of HPV and its clinical manifestations and to update clinicians on strategies to prevent genital HPV infection and cervical cancer that are consistent with national guidelines.

Objectives
Upon successful completion of the program, participants will be able to:
  • Identify the two types of genital HPV infection.
  • Discuss the epidemiology of genital HPV infection in the United States.
  • Describe the natural history of genital HPV infection.
  • Identify methods used to detect cervical cellular abnormalities for the prevention of cervical cancer.
  • Summarize appropriate patient counseling messages for genital HPV infection.
  • Identify methods for preventing genital HPV infection.
Target Audience
Obstetricians, Gynecologists, Physicians in Family and General Practice, General Internists, Advanced Practice Nurses, Physicians Assistants, and Nurses

Presenters
Julie Louise Gerberding, MD, MPH, Director, Centers for Disease Control and Prevention
John M. Douglas, Jr. MD, Director, Division of Sexually Transmitted Disease Prevention, National Center for HIV, STD, & TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention
Mona Saraiya, MD, MPH, Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, National Center for Health Promotion, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention
Thomas C. Wright, MD, Associate Professor of Pathology, Department of Pathology, College of Physicians and Surgeons, Columbia University

Continuing Education Information
Continuing Education will be available by registering and completing an evaluation at www.phppo.cdc.gov/phtnonline. The origination date of this webcast is August 9, 2005. Continuing education credits will be offered for various professions based on 1 hour of instruction. CE registration will be available from July 21, 2005 through August 9, 2006.

Course Number:
Web-on-Demand - WD0075


Webcast Information
This program will be available for viewing on and after August 9, 2005, at http://www.phppo.cdc.gov/PHTN/webcast/HPV-05

Contact Information
We will not be taking questions during this webcast. However, we will be accepting your questions about HPV via e-mail, cdcinfo@cdc.gov, until June 30. Our panellists will answer some of these questions at the end of the webcast and all responses will be posted on our website at http://www.cdc.gov/std/HPV/webcastQA-2005.htm. You may also submit questions to the same e-mail address after the webcast.

Audiobridge Information
In the event you are unable to receive the signal on program day, you may join by audiobridge. For security reasons, the passcode will be required to join the call.
DATE: August 09, 2005
TIME: 1:00 PM EDT
DURATION: 1 HOUR
TOLL FREE NUMBER: 888-560-6184
TOLL NUMBER: 210-234-6722
PASSCODE: 4972266
If you have problems during your audiobridge conference, you may call 800-728-8232 or International callers dial 404-639-1289.
For a fax copy of this fact sheet, contact the CDC Fax Information System at 888-232-3299 (or 877-232-1010 for the hearing impaired). When prompted, enter the document number 130036 and a return fax number.

PHTN Home Page   

This page last reviewed: May 25, 2005
spacer
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
spacer USA.gov: The U.S. Government's Official Web Portal DHHS Department of Health
and Human Services